Irina Voronov
Toronto, ON, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Novel c.G630A TCIRG1 mutation causes aberrant splicing resulting in an unusually mild form of autosomal recessive osteopetrosis.
Journal: Journal of cellular biochemistry
Published: December 23, 2018
V-ATPases Containing a3 Subunit Play a Direct Role in Enamel Development in Mice.
Journal: Journal of cellular biochemistry
Published: February 10, 2017
Activity-independent targeting of mTOR to lysosomes in primary osteoclasts.
Journal: Scientific reports
Published: January 04, 2017
Lysosomal pH Plays a Key Role in Regulation of mTOR Activity in Osteoclasts.
Journal: Journal of cellular biochemistry
Published: May 05, 2015
The R740S mutation in the V-ATPase a3 subunit results in osteoclast apoptosis and defective early-stage autophagy.
Journal: Journal of cellular biochemistry
Published: July 16, 2013
Osteopetrosis mutation R444L causes endoplasmic reticulum retention and misprocessing of vacuolar H+-ATPase a3 subunit.
Journal: The Journal of biological chemistry
Published: June 12, 2012
The R740S mutation in the V-ATPase a3 subunit increases lysosomal pH, impairs NFATc1 translocation, and decreases in vitro osteoclastogenesis.
Journal: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research
Published: January 10, 2012
Benzo[a]pyrene inhibits osteoclastogenesis by affecting RANKL-induced activation of NF-kappaB.
Journal: Biochemical pharmacology
Published: December 19, 2007
Inhibition of osteoclast differentiation by polycyclic aryl hydrocarbons is dependent on cell density and RANKL concentration.
Journal: Biochemical pharmacology
Published: January 18, 2005
Showing 1-11 of 11
Last Updated: 09/26/2026